✦ LIBER ✦

Health Economics: Cost of Disease

Book ID: 109669278
Publisher: Nature Publishing Group
Year: 1969
Tongue: English
Weight: 184 KB
Volume: 224
Category: Article
ISSN: 0028-0836
DOI: 10.1038/2241147a0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Health-economic analysis: cost-effective

Health-economic analysis: cost-effectiveness of scheduled maintenance treatment with infliximab for Crohn’s disease – modelling outcomes in active luminal and fistulizing disease in adults

✍ J. LINDSAY; Y. S. PUNEKAR; J. MORRIS; G. CHUNG-FAYE 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

The economic burden to the public health

The economic burden to the public health system of treating non-viral injecting-related injury and disease in Australia (a cost of illness analysis)

✍ Rohan Sweeney; Andrew B. Conroy; Robyn Dwyer; Campbell K. Aitken 📂 Article 📅 2009 🏛 Public Health Association of Australia 🌐 English ⚖ 124 KB

The incidence and economic costs of majo

The incidence and economic costs of major health impairments: A comoarative Analysis cancer, motor vehicle injuries, coronary heart disease, and stroke: Nelson S. Hartunian, Charles N. Smart and Mask S. Thompson. D.C. Health and Company, Lexington, MA 1981. 420 pp. $34.95.

✍ Votey Jr.; Harold L. 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 211 KB

This book represents a major effort to isolate and compile detailed cost estimates of societal losses associated with the incidence of cancer. coronary heart disease. motor vehicle injuries, and stroke. The authors point out that knowing the relative impacts on society of these major sources of deat

Health Service: Costs of Disease

📂 Article 📅 1969 🏛 Nature Publishing Group 🌐 English ⚖ 260 KB

Health economic evaluation of disease ma

Health economic evaluation of disease management programs

✍ Wolfgang Greiner 📂 Article 📅 2005 🏛 Springer 🌐 French ⚖ 568 KB

Economic evaluation and the postponement

Economic evaluation and the postponement of health care costs

✍ Pieter H. M. van Baal; Talitha L. Feenstra; Johan J. Polder; Rudolf T. Hoogenvee 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

The inclusion of medical costs in life years gained in economic evaluations of health care technologies has long been controversial. Arguments in favour of the inclusion of such costs are gaining support, which shifts the question from whether to how to include these costs. This paper elaborates on